04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
GOVERNMENT CONTRACTS LAW - Late Is Late—Even on the GSA Schedule - In a recent blog, we discuss...
Read More >
During the 2019 legislative session, the Maryland General Assembly passed a new bill called “Crimin...
Read More >
The National Labor Relations Board recently overturned a decision issued in 2014 and returned to its...
Read More >
In 2011 and 2012, the New York Court of Appeals decided a series of difficult cases addressing the c...
Read More >
- Employees working for covered employers in the District of Columbia will become eligible for Unive...
Read More >
The New Jersey Department of Labor and Workforce Development (the “Department”) has issued its fin...
Read More >